newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics Announces Proposed Public Offering

SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ:MRTX), a commercial stage biotechnology company, today announced that it intends to offer and sell $250.0 million of shares of its common stock,